SEC Form 4 · accession 0001209191-18-042890
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David T Howton
Officer — SVP, General Counsel
Period of report
Jul 16, 2018
Accepted (ET)
Jul 17, 2018 · 6:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 16, 2018 | M | 3,096 | $13.71 | A | 37,967 | D | |
| Common StockF1 | Jul 16, 2018 | S | 3,096 | $136.46 | D | 34,871 | D | |
| Common StockF1 | Jul 16, 2018 | M | 9,056 | $13.71 | A | 43,927 | D | |
| Common StockF1 | Jul 16, 2018 | S | 9,056 | $136.46 | D | 34,871 | D | |
| Common StockF1 | Jul 16, 2018 | M | 37,848 | $13.90 | A | 72,719 | D | |
| Common StockF1 | Jul 16, 2018 | S | 37,848 | $136.46 | D | 34,871 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $13.71 | Jul 16, 2018 | M | 3,096 | D | Feb 28, 2017 | Feb 28, 2026 | Common Stock | 3,096 | 7,431 | D |
| Stock option (right to buy)F1 | $13.71 | Jul 16, 2018 | M | 9,056 | D | Feb 28, 2017 | Feb 28, 2026 | Common Stock | 9,056 | 10,090 | D |
| Stock option (right to buy)F1 | $13.90 | Jul 16, 2018 | M | 37,848 | D | Feb 27, 2016 | Feb 27, 2025 | Common Stock | 37,848 | 27,159 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.